Skip to main navigation Skip to search Skip to main content

Response to “comment on CSF and plasma GFAP and VEGF in adult type 3 spinal muscular atrophy patients treated with nusinersen”

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Article number125856
JournalJournal of the Neurological Sciences
Volume484
DOIs
Publication statusPublished - 15 May 2026
Externally publishedYes

Keywords

  • Biomarkers
  • Dear Editor,
  • GFAP
  • Nusinersen
  • SMA
  • VEGF

Cite this